Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET ‐adapted strategy-Reference-Cited by-同舟云学术

Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET ‐adapted strategy

Published:2020-07-30 Issue:4 Volume:38 Page:501-508
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Viviani Simonetta¹^ORCID,Mazzocchi Arabella²,Pavoni Chiara³,Taverna Francesca²,Rossi Andrea³,Patti Caterina⁴,Romano Alessandra⁵,Trentin Livio⁶,Sorasio Roberto⁷,Guidetti Anna¹,Gottardi Daniela⁸,Tarella Corrado⁹¹⁰,Cimminiello Michele¹¹,Zanotti Roberta¹²^ORCID,Farina Lucia¹,Ferreri Andrés José Maria¹³^ORCID,Galbiati Marina²,Corradini Paolo¹,Gianni Alessandro Massimo¹,Gallamini Andrea⁷,Rambaldi Alessandro³¹⁴

Affiliation:

1. Department of Hemato‐Oncology Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

2. Immuno‐hematology and Transfusion Medicine Service Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

3. Department of Oncology and Hematology Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo Italy

4. Division of Hematology 1 Azienda Ospedali Riuniti Villa Sofia‐Cervello Palermo Italy

5. Department of Medical and Surgery Science, Hematology Unit University of Catania Catania Italy

6. Department of Hematology University of Padova Padova Italy

7. Division of Hematology Azienda Ospedaliera Santa Croce e Carle Cuneo Italy

8. Division of Hematology Ospedale Mauriziano Umberto I di Torino Turin Italy

9. Hemato‐Oncology Division European Institute of Oncology IRCCS Milan Italy

10. University Department “Scienze della Salute” (DISS) University of Milan Milan Italy

11. Divisione Universitaria di Ematologia Ospedale San Carlo Potenza Italy

12. Hematology Unit, Department of Medicine Azienda Ospedaliera Universitaria Integrata di Verona Verona Italy

13. Lymphoma Unit, Department of Onco‐Hematology IRCCS Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele Milan Italy

14. Department of Oncology and Hematology University of Milan Milan Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2775

Reference28 articles.

1. Elevated Serum Levels of CC Thymus and Activation-Related Chemokine (TARC) in Primary Hodgkin's Disease: Potential for a Prognostic Factor

2. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22

3. High Expression of the CC Chemokine TARC in Reed-Sternberg Cells

4. Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells

5. Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin lymphoma and liquid biopsy: a story to be told;Journal of Experimental & Clinical Cancer Research;2024-07-02

2. Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma;Cancer Research Communications;2024-07-01

3. Molecular biomarkers in classic Hodgkin lymphoma;Seminars in Hematology;2024-05

4. Long-term outcomes for patients with Hodgkin lymphoma at increased risk of progression or relapse;Leukemia & Lymphoma;2022-10-10

5. Thymus and activation‐regulated chemokine ( TARC ) as treatment response marker for paediatric Hodgkin lymphoma: A pilot study;British Journal of Haematology;2022-09-20